PublisherDOIYearVolumeIssuePageTitleAuthor(s)Link
Kidney Research and Clinical Practice10.23876/j.krcp.20.2202021403411-418Hyperuricemia is a risk factor for the progression to end-stage renal disease in minimal change diseaseSu Hyun Song, Tae Ryom Oh, Hong Sang Choi, Chang Seong Kim, Dong Ryeol Ryu, Sung Gyun Kim, Sun-Hee Park, Seong Kwon Ma, Soo Wan Kim, Eun Hui Bae, http://www.krcp-ksn.org/upload/pdf/j-krcp-20-220.pdf, http://www.krcp-ksn.org/journal/view.php?doi=10.23876/j.krcp.20.220, http://www.krcp-ksn.org/upload/pdf/j-krcp-20-220.pdf
Pediatrics & Neonatology10.1016/j.pedneo.2015.05.0052016574263-264Albuminuria in Childhood is a Risk Factor for Chronic Kidney Disease and End-Stage Renal DiseaseChi-Hui Chenghttps://api.elsevier.com/content/article/PII:S1875957216300742?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S1875957216300742?httpAccept=text/plain
Journal of Renal Care10.1111/j.1755-6686.2007.tb00053.x2007333105-107HOW TO PREVENT PROGRESSION TO END STAGE RENAL DISEASEMarkus Riegersperger, Gere Sunder-Plassmannhttps://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fj.1755-6686.2007.tb00053.x, http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1755-6686.2007.tb00053.x/fullpdf
Psychosocial Care of End-Stage Organ Disease and Transplant Patients10.1007/978-3-319-94914-7_5201863-71Chronic and End-Stage Renal Disease and Indications for Renal TransplantationAdetokunbo Taiwohttp://link.springer.com/content/pdf/10.1007/978-3-319-94914-7_5
Kidney International10.1038/ki.2014.262015871242Corrections to "Individuals of Pacific Asian origin with IgA nephropathy have an increased risk of progression to end-stage renal disease"https://api.elsevier.com/content/article/PII:S0085253815300016?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S0085253815300016?httpAccept=text/plain
Diabetic Medicine10.1002/(sici)1096-9136(1998120)15:4+3.0.co;2-y199815S4S51-S56Preventing end-stage renal diseaseCarl Erik Mogensenhttps://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2F%28SICI%291096-9136%281998120%2915%3A4%2B%3CS51%3A%3AAID-DIA740%3E3.0.CO%3B2-Y, http://onlinelibrary.wiley.com/wol1/doi/10.1002/(SICI)1096-9136(1998120)15:4+3.0.CO;2-Y/fullpdf
Science-Business eXchange10.1038/scibx.2013.2762013611276-276Carbamylated serum albumin as a risk factor for mortality in end-stage renal disease (ESRD)http://link.springer.com/content/pdf/10.1038/scibx.2013.276.pdf, http://link.springer.com/article/10.1038/scibx.2013.276/fulltext.html, http://link.springer.com/content/pdf/10.1038/scibx.2013.276.pdf
Nephrology10.1046/j.1440-1797.8.s.8.x20038S40-S44C-reactive protein as a cardiovascular risk factor and its therapeutic implications in end-stage renal disease patientsJung Sik PARK, Soon Bae KIMhttps://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1046%2Fj.1440-1797.8.s.8.x, https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1046%2Fj.1440-1797.8.s.8.x, http://onlinelibrary.wiley.com/wol1/doi/10.1046/j.1440-1797.8.s.8.x/fullpdf
Transplantation Proceedings10.1016/s0041-1345(98)02040-51999311-21393-1394Focal segmental glomerulosclerosis progression to end-stage renal disease within 48 months is a risk factor for recurrence after pediatric renal transplantationS.J Kim, M Kim, J Ha, I.M Jung, T.S Lee, H.I Cheong, Y Choi, H.S Leehttps://api.elsevier.com/content/article/PII:S0041134598020405?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S0041134598020405?httpAccept=text/plain
Mayo Clinic Proceedings10.1016/j.mayocp.2017.12.0182018932133-135Disease Progression and End-Stage Renal Disease in Diverse GlomerulopathiesKarl A. Nath, Fernando C. Fervenzahttps://api.elsevier.com/content/article/PII:S0025619617309217?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S0025619617309217?httpAccept=text/plain